Tower Research Capital (TRC)’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,709
| Closed | -$4.51K | – | 6442 |
|
|
2023
Q2 | $4.51K | Buy |
6,709
+1,701
| +34% | +$1.14K | ﹤0.01% | 4918 |
|
|
2023
Q1 | $7K | Buy |
5,008
+4,295
| +602% | +$6K | ﹤0.01% | 4804 |
|
|
2022
Q4 | $1K | Sell |
713
-798
| -53% | -$1.12K | ﹤0.01% | 5771 |
|
|
2022
Q3 | $6K | Buy |
+1,511
| New | +$6K | ﹤0.01% | 5097 |
|
|
2022
Q2 | – | Sell |
-766
| Closed | -$9K | – | 6798 |
|
|
2022
Q1 | $9K | Buy |
766
+158
| +26% | +$1.86K | ﹤0.01% | 4525 |
|
|
2021
Q4 | $12K | Sell |
608
-72
| -11% | -$1.42K | ﹤0.01% | 4357 |
|
|
2021
Q3 | $17K | Sell |
680
-441
| -39% | -$11K | ﹤0.01% | 3900 |
|
|
2021
Q2 | $25K | Buy |
1,121
+788
| +237% | +$17.6K | ﹤0.01% | 3703 |
|
|
2021
Q1 | $8K | Buy |
+333
| New | +$8K | ﹤0.01% | 4495 |
|
|
2020
Q3 | – | Sell |
-9,431
| Closed | -$108K | – | 5201 |
|
|
2020
Q2 | $108K | Buy |
+9,431
| New | +$108K | ﹤0.01% | 2390 |
|
|
2019
Q3 | – | Sell |
-130
| Closed | -$3K | – | 4653 |
|
|
2019
Q2 | $3K | Buy |
+130
| New | +$3K | ﹤0.01% | 3189 |
|
|
2019
Q1 | – | Sell |
-220
| Closed | -$10K | – | 4459 |
|
|
2018
Q4 | $10K | Buy |
+220
| New | +$10K | ﹤0.01% | 2488 |
|
|
2017
Q2 | – | Sell |
-3
| Closed | -$1K | – | 3751 |
|
|
2017
Q1 | $1K | Buy |
3
+1
| +50% | +$333 | ﹤0.01% | 2883 |
|
|
2016
Q4 | $1K | Sell |
2
-2
| -50% | -$1K | ﹤0.01% | 3687 |
|
|
2016
Q3 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 3416 |
|